Pricing

ImaRx Theraputcs (IMRX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION
1635 E 18TH ST TUCSON, AZ 85719

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • IMarx Therapeutics

Are you looking for this stock instead?

ImaRx Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for vascular disorders. It focuses on developing therapies for stroke and other vascular disorders, using its proprietary microbubble technology to treat vascular occlusions, or blood vessel blockages, as well as the resulting ischemia, which is tissue damage caused by a reduced supply of oxygen. The company offers Abbokinase, a urokinase product, which is used for the treatment of acute massive pulmonary embolism. Its development stage product candidates include SonoLysis+tPA therapy, which is in Phase I clinical trials and involves the administration of MRX-801 microbubbles, ultrasound, and the thrombolytic drug alteplase, or tPA and used for the treatment of ischemic stroke; SonoLysis therapy that involves the administration of its MRX-801 microbubbles with ultrasound for the treatment of ischemic stroke, which is in preclinical stage; and NanO2 that utilizes its proprietary MRX-804 microbubbles for carrying oxygen to parts of the body afflicted with a reduced supply of blood or oxygen, which is in preclinical research stage. The company was founded in 1999 and is headquartered in Tucson, Arizona.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available